Tivity Health — Healthways — Proxy Contest (April 2014)
48 slides from Tivity Health's proxy contest presentation, Apr 1, 2014
Slide 1: Healthways: The Case for Change
HEALTHWAYS: Presentation to Healthways Shareholders THE CASE FOR CHANGE April 2014
Slide 2: Disclaimer
DISCLAIMER THIS PRESENTATION IS FOR DISCUSSION AND GENERAL INFORMATIONAL PURPOSES ONLY. IT DOES NOT HAVE REGARD TO THE SPECIFIC INVESTMENT OBJECTIVE, FINANCIAL SITUATION, SUITABILITY, OR THE PARTICULAR NEED OF ANY SPECIFIC PERSON WHO MAY RECEIVE THIS PRESENTATION, AND SHOULD NOT BE TAKEN AS ADVICE O
Slide 3: Executive Summary: Introduction
EXECUTIVE SUMMARY INTRODUCTION Healthways shareholder s have suf fered subs tantial value des truction over th e pas t dec ade and yet th e Boar d h as done noth ing to ac knowledge and address th e need for c h ange, or h old management ac c ountable for its terrible f inanc ial per formanc e and
Slide 4: Executive Summary: The Case for Change: Abysmal Performance
EXECUTIVE SUMMARY THE CASE FOR CHANGE: ABYSMAL PERFORMANCE HWAY’s per formance recor d has been abysmal on almos t any metric over the pas t dec ade, and yet th e Boar d h as done noth ing to ac knowledge or c orrec t the situation H WAY s h a r e s h ave d r a m a t i c a l l y u n d e r p e r f
Slide 5: The Board's Actions and Statements Supporting the Status Quo Make No Sense
EXECUTIVE SUMMARY THE BOARD’S ACTIONS AND STATEMENTS SUPPORTING THE “STATUS QUO” MAKE NO SENSE Healthways ’ Boar d has inexplicably maintained its suppor t for the s tr ategy and management team c urrently in plac e despite th e terrible tr ac k rec or d, repeated sh or tfalls, and a “c all to ac ti
Slide 6: A Chance to Set a New Course
EXECUTIVE SUMMARY A CHANCE TO SET A NEW COURSE If elected, the Nor th Tide slate would immediately seek to initiate a strategic and financial review of the Company focused on: The Silver Sneaker s business, which contrar y to managem ent commentar y, remains a highly separ ate and distinct busines
Slide 7: Shareholders Have Already Spoken
EXECUTIVE SUMMARY SHAREHOLDERS HAVE ALREADY SPOKEN Since we filed our 13 -D on 10/28/13, HWAY shares have appreciated more than 50% despite : The company missing 4Q13 earnings and reducing 2014 profit estimates, just a few months after lowering guidance following it’s 3Q13 miss The Company’s Fou
Slide 8: The Sellside Is Almost Universally Bearish on HWAY
EXECUTIVE SUMMARY T H E SE LLSI DE I S A LM OST UN I VE RSALLY BE A RI SH ON H WAY “Earnings misses are not created equal. When a company lays out its opportunities and the risks, and it turns out that one of the risks was quite real, resulting in an earnings miss, the stock has a bad day, but life
Slide 9: Founder's Resignation Letter Validates Our View
EXECUTIVE SUMMARY FOUN DE R’S RE SI GN ATI ON LE T T ER VA LI DATE S OUR VI E W Dear John, I t i s w i t h g r e a t r e g r e t t h a t I r e s i g n f r o m t h e B o a r d o f D i r e c to r s o f H e a l t h way s , I n c e f f e c t i v e i m m e d i a t e l y. Over the last 3 years, I have tri
Slide 10: The North Tide Slate
EXECUTIVE SUMMARY THE NORTH TIDE SLATE N o r t h T i d e h a s n o m i n a te d a s l a te w h o w o u l d b r i n g a n o u t s t a n d i n g r e c o r d o f s i g n i f i c a n t s h a r e h o l d e r v a l u e c r e a t i o n , d e e p h e a l t h c a r e o p e r a t i n g e x p e r t i s e , a n
Slide 11: The North Tide Slate Would Bring Substantial Healthcare Experience to the Board
EXECUTIVE SUMMARY THE NORTH TIDE SLATE WOULD BRING SUBSTANTIAL HEALTHCARE EXPERIENCE TO THE BOARD North Tide Slate Mac Crawford Brad Karro Paul Keckley Conan Laughlin Relevant Former Chairman, CVS Executive VP at Former Executive Founder and Portfolio Healthcare / Caremark Caremark 1998-2007
Slide 12: Mac Crawford's Record of Shareholder Value Creation at Caremark
EXECUTIVE SUMMARY MAC CRAWFORD’S RECORD OF SHAREHOLDER VALUE CREATION AT CAREMARK WAS OUTSTANDING 600% 500% +516% 400% 300% 200% 100% +52% +47% 0% Mar-98 Nov-98 Mar-99 Mar-00 Mar-01 Mar-02 Mar-03 Mar-04 Mar-05 Mar-06 Mar-07 Nov-99 Nov-00 Nov-01 Nov-02 Jul-03 Nov-03 Nov-04 Nov-05 Nov-06 Jul-98 Jul-99
Slide 13: A Decade of Value Destruction
A DECADE OF VALUE DESTRUCTION 13
Slide 14: Total Shareholder Return Has Been Horrific Over the Past Ten Years
TOTAL SHAREHOLDER RETURN HAS BEEN HORRIFIC OVER THE PAST TEN YEARS 250% 200% 150% +127% 100% +107% 50% 0% Feb-07 Feb-04 Jun-04 Feb-05 Jun-05 Feb-06 Jun-06 Jun-07 Feb-08 Jun-08 Feb-09 Jun-09 Feb-10 Jun-10 Oct-10 Feb-11 Jun-11 Feb-12 Jun-12 Feb-13 Jun-13 Oct-03 Oct-04 Oct-05 Oct-06 Oct-07 Oct-08 Oct-0
Slide 15: Total Shareholder Return Has Been Horrific Over Almost Any Measuring Period
TOTAL SHAREHOLDER RETURN HAS BEEN HORRIFIC OVER ALMOST ANY MEASURING PERIOD One year Three year 140% 120% 120% 100% 100% 80% +80% 80% 60% +59% 60% +35% 40% 40% 20% +9% 20% +27% 0% +17% 0% Feb-13 Feb-11 Feb-12 Jun-11 Jun-12 Jun-13 Oct-10 Oct-11 Oct-12 -20% Apr-13 May-13 Dec-12 Jan-13 Feb-13 Jun-13 Au
Slide 16: HWAY Shares Have Also Significantly Underperformed Versus Peers
HWAY SHARES HAVE ALSO SIGNIFICANTLY UNDERPERFORMED VERSUS PEERS Stock price performance through 10/28/13 Last Last Last Last Last Last ten yrs five yrs four yrs three yrs two yrs 12 mos S&P 500 Index 68% 87% 69% 49% 37% 25% S&P Healthcare Index 87% 98% 87% 69% 55% 31% Peer avg(1) 222% 383% 166% 115%
Slide 17: EBITDA Declined 64% Over the Last 5 Years, and 52% Over the Last 2
EBITDA DECLINED 64% OVER THE LAST 5 YEARS, AND 52% OVER THE LAST 2 YEARS $800 30% $700 25% $600 20% $500 $400 15% $300 10% $200 5% $100 $0 0% 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Revenue EBITDA EBITDA margin % Note: Dollar figures in millions. Healthways reported a fiscal year end
Slide 18: EPS Decline Has Been Precipitous
EPS DECLINE HAS BEEN PRECIPITOUS $1.60 $1.40 $1.20 $1.00 $0.80 $0.60 $0.40 $0.20 $0.00 ($0.20) ($0.40) Note: Healthways reported a fiscal year end of 11/30 through 2007. Starting 2008 fiscal year ends 12/31. 18
Slide 19: The Company Is Dangerously Close to Violating Its Debt Covenants
THE COMPANY IS DANGEROUSLY CLOSE TO VIOLATING ITS DEBT COVENANTS Despite having continuously modified the coverage levels under its debt covenants, Healthways remains dangerously close to violating these levels F2012A F2013A F2014E 1QA 2QA 3QA 4QA 1QA 2QA 3QA 4QA 1QE 2QE 3QE 4QE Mar-12 Jun-12 Sep-12
Slide 20: Management and the Board Have Been Terrible Stewards of Capital
MANAGEMENT AND THE BOARD HAVE BEEN TERRIBLE STEWARDS OF CAPITAL Over t he last 10 years under the current leadership: H e a l t h w ay s h a s s p e n t $ 1 . 0 2 b n o n c a p i t a l ex p e n d i t u r e s a n d a c q u i s i t i o n s to g e n e r a t e c u m u l a t i ve E B I T DA o f $ 1 . 0
Slide 21: Management Has Missed Its Internal Targets in 6 Out of the Past 10 Years
MANAGEMENT HAS MISSED ITS INTERNAL TARGETS IN 6 OUT OF THE PAST 10 YEARS Y ear Target Actual C om m ent in prox y "Mr. Leedle did not receive an Annual Incentive Compensation plan award for fiscal 2004 because the Company did not 2004 Not disclosed $0.75 achieve certain internal revenue and earnings
Slide 22: Compensation Has Been Improperly Structured for Years
COMPENSATION HAS BEEN IMPROPERLY STRUCTURED FOR YEARS Healthways policies North Tide’s View H e a l t h w a y s L o n g T e r m I n c e n t i v e H e a l t h w a y s p e r f o r m a n c e b a s e d compensation is based entirely on revenue compensation should incentivize profitable growth for 2013
Slide 23: Management Turnover Below the CEO Level Has Been a Constant
MANAGEMENT TURNOVER BELOW THE CEO LEVEL HAS BEEN A CONSTANT There have been 4 COOs over the past 10 years, with the longest tenure at 3 years Donald Taylor, 2003-2005 James Pope, 2006-2008, Stefen Brueckner, 2009-2010 Thomas Cox, 2011-2012 There has been no COO since Thomas Cox resigned in 2
Slide 24: Management Turnover Below the CEO Level Has Been a Constant
MANAGEMENT TURNOVER BELOW THE CEO LEVEL HAS BEEN A CONSTANT Exec VP/Chief Exec VP, Chief VP, Science Chief Science Chief Medical Exec VP/Chief Strategy President, Chief Accounting VP, Employer VP and General Commercial CEO CFO COO Senior Advisor & Value Officer Officer S&M officer officer Exec VP Ex
Slide 25: Management and Board Ownership Is Minimal
MANAGEMENT AND BOARD OWNERSHIP IS MINIMAL HWAY management and Board own less than 2% of the shares outstanding; Tom Cigarran was the only member of the Board with any meaningful ownership (~1%) prior to his resignation. Board Members and Total % Shares Executive Officers Title Shares Owned Outstandi
Slide 26: The Board Lacks Meaningful, Relevant Healthcare Operating Experience
THE BOARD LACKS MEANINGFUL, RELEVANT HEALTHCARE OPERATING EXPERIENCE Public Board experience Current number of boards Name Position Director since Age Relevant healthcare experience other than Healthways service (public and private) John Ballantine Director, Chairman 2003 67 None Portland General El
Slide 27: The Value Opportunity
THE VALUE OPPORTUNITY 27
Slide 28: We See Considerable Value in HWAY Shares Under New Leadership
WE SEE CONSIDERABLE VALUE IN HWAY SHARES UNDER NEW LEADERSHIP We believe t here is considerable value in HWAY shares t hat can be unlocked with new leader ship; nominating o ur slate represents t he f ir st s tep in t hat process Silver Sneaker s as a stand -alone business could be wor th $1B+ whi
Slide 29: Silver Sneakers: A Brief Overview
SILVER SNEAKERS A BRIEF OVERVIEW W ha t i s S i l ve r S n e ake r s? S i l ve r S n e a ke r s i s e s s e n t i a l l y a n a f f i n i t y m a r ket i n g p r o g r a m d e s i g n e d to g et s e n i o r s to l i ve a m o r e a c t i ve a n d f i t l i f e s t y l e ; r o u g h l y 11 M M s e
Slide 30: Silver Sneakers: The Economics of the Business
SILVER SNEAKERS THE ECONOMICS OF THE BUSINESS We c o n d u c te d a n i n - d e pt h a n a l ys i s t o b e t te r u n d e r s t a n d t h e e c o n o m i c s o f t h e S i l ve r S n e a ke r s b u s i n e ss , i n c l u d i n g c o nve r sa t i o n s w i t h h e a l t h p l a n s a n d a s u r vey
Slide 31: Silver Sneakers: The Value to HWAY Shareholders
SILVER SNEAKERS THE VALUE TO HWAY SHAREHOLDERS At a 10x EBITDA multiple, Silver Sneaker s could be wor th $24/share: (1) Silver Sneakers Revenue $291,845,400 Silver Sneakers gyms(2) 15,000 x Avg payment to gym, per month(3) $688 x months 12 - Estimated cost of gyms, annually $123,795,000 - Additiona
Slide 32: Silver Sneakers: Final Thoughts
SILVER SNEAKERS FINAL THOUGHTS H e a l t h ways ’ m a n a g e m e n t a n d t h e B o a r d h ave p r ov i d e d m i n i m a l d i s c l os u r e t o h e l p i n ve s to r s e v a l u a te t h e S i l ve r S n e a ke r s b u s i n e ss , a n d t h e r e f or e w e h ave h a d t o m a ke a n u m b
Slide 33: The Core Business: A Mismanaged Asset with Great Potential
THE CORE BUSINESS: A MISMANAGED ASSET WITH GREAT POTENTIAL Excluding Silver Sneakers, we estimate the core business has experienced a precipitous decline in revenue and EBITDA $700 30% 25% $600 20% $500 15% $400 10% Revenue $300 5% EBITDA EBITDA margin % 0% $200 -5% $100 -10% $0 -15% 2003 2004 2005
Slide 34: Fixing the Core Business Would Be Significantly Accretive to EBITDA
FIXING THE CORE BUSINESS WOULD BE SIGNIFICANTLY ACCRETIVE TO EBITDA We estimate getting the core business to breakeven would add up to $50MM to consolidated in EBITDA Im plied Total HWAY Silver Sneak ers International core business Revenue $663 $292 $27 $345 EBITDA $55 $108 $0 ($53) EBITDA marg in %
Slide 35: The Board Should Consider Exiting the International Business
THE BOARD SHOULD CONSIDER EXITING THE INTERNATIONAL BUSINESS HWAY’s International segment has never lived up to the hype, has not contributed to earnings, and in all likelihood represents an unnecessar y distraction for management International segm ent perform ance Year end Oct-07 Oct-08 Dec-09 Dec
Slide 36: A Pattern of Overpromising and Underdelivering
A PATTERN OF OVERPROMISING AND UNDERDELIVERING 36
Slide 37: Management "Hype" Has Been a Big Part of the Problem in Our View
MANAGEMENT “HYPE” HAS BEEN A BIG PART OF THE PROBLEM IN OUR VIEW We have documented a consis tent pattern of management irresponsibly promoting various growth oppor tunities, and downplaying potential risks, mos t of wh ic h h ave gone th e “wrong way”, and sh areh older s h ave suf fered greatly
Slide 38: Hype: Things Are Getting Better, 2010-2014
HYPE: THINGS ARE GETTING BETTER, 2010-2014 H y p e : H e a l t h w ays M a n a g e m e n t a n d B o a r d h ave c o n s i s te n t l y t o u te d t h e “ s t r o n g b u s i n e s s d eve l o p m e n t ” a n d “ m o m e n t u m ” i n t h e C o m p a ny ’s a n n u a l r e p o r t s a n d p u b l i c
Slide 39: Hype: Medicare Pilot, 2007
HYPE: MEDICARE PILOT, 2007 Hype: Healthways participated in two Medicare Health Support (MHS) pilot programs for Medicare enrollees with chronic diseases, primarily Diabetes and Heart Disease, in 2005 -2006. Management promoted the potential full roll -out of these programs to the entire Medicare po
Slide 40: Hype: Insourcing Is Not a Trend, 2008
HYPE: INSOURCING IS NOT A TREND, 2008 H y p e : D e s p i te b e i n g w e l l v e t te d b y a n a l ys t s , H e a l t h w ays ’ m a n a g e m e n t d i r e c t l y d e n i e d t h e t r e n d t ow a r d i n s o u r c i n g a s a r i s k t o t h e i r b u s i n e s s, m e r e m o n t h s b e f o r
Slide 41: Hype: Int'l Opportunity, 2006-Present
HYPE: INT’L OPPORTUNIT Y, 2006 -PRESENT Hype: Healthways management has been promoting the international growth opportunity since January 2006 Ben Leedle 1/9/2006: “Real quickly, just briefly, we have sized the early international market based on just a few countries that we're interacting with as b
Slide 42: Hype: Int'l Opportunity, 2006-Present
HYPE: INT’L OPPORTUNIT Y, 2006 -PRESENT Ben Leedle 3/23/2010: “And then, obviously, we are early in the international market. Our outcomes that get delivered this year of our first contract in Germany and the opportunity to expand off that will drive the growth. So we think we are credibly well posi
Slide 43: Hype: ACO Opportunity, 2013
HYPE: ACO OPPORTUNIT Y, 2013 H y p e : I n 2 01 3 , H e a l t h w ays ’ m a n a g e m e n t b e g a n p r o m ot i n g t h e g r ow t h o p p o r t u n i t y f r o m A c c o u n t a b l e C a r e O r g a n i z a t i o n s ( ACO s ) , s p e c i f i c a l l y w i t h h e a l t h s y s te m s c u s to
Slide 44: Appendix: The North Tide Slate
APPENDIX: THE NORTH TIDE SLATE 44
Slide 45: Edwin "Mac" Crawford
EDWIN “MAC” CRAWFORD E dw i n “ M ac ” C r aw fo r d m o st r ec e n t l y s er v ed as C h ai r m a n o f C VS C ar em a r k , a Fo r t u n e 2 0 c o m p a ny fo r m ed by t h e 2 0 07 m er g e r o f C VS a nd C ar em ar k R x . Fro m 1 9 9 8 - 2 0 07 , M r. C r aw fo r d wa s C E O o f C ar em ar
Slide 46: Bradley S. Karro
BRADLEY S. KARRO Br ad l ey S . K ar ro i s a pr i nc i pal o f H i l lc ote Ad v i s o r s , a fi r m fo c use d o n i nv est i ng i n a nd r e s t r uc t ur i ng h e a l t hc ar e c o m pa n i es . P r i o r to fo u nd i ng H i l lco te , M r. K ar ro h el d a n u m b er o f s e nio r exec ut i v
Slide 47: Paul H. Keckley
PAUL H. KECKLEY Pau l H . Kec k l ey i s t h e E di to r o f T h e Kec kl ey Rep o r t a nd a n ex pe r t o n h e al t h i ndust r y t r e nd s a nd U . S . h e a l t h s y s tem r e fo r m . I n hi s t hi r t y - fi v e ye ar h e al t h i nd us t r y c ar ee r, D r. Kec kl ey s er v ed a s a n ex p
Slide 48: Conan J. Laughlin
CONAN J. LAUGHLIN C o n a n J . L aug h li n i s t h e Fo u nd e r, Po r t fo l i o M an a g er, a nd M a na g i ng M em ber o f No r t h T i d e C ap i t al L LC , a B o s to n - b as ed i nv es t m e nt fi r m w i t h ov er $ 1 b i l li o n i n a s s et s u nd er m a n ag em e nt . T h e fi r m i